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Statistics from the Northern Ireland Drug Misuse Database: 1 
April 2011 – 31 March 2012 
 
This bulletin summarises information on people presenting to services with problem drug 
misuse and relates to the 12-month period ending 31 March 2012. It is the eleventh bulletin 
reporting on information collected through the Northern Ireland Drug Misuse Database 
(DMD), which was established in April 2000 and which collects detailed data on those 
presenting for treatment, including information on drugs misused and injecting behaviour. 
 
Summary 
 
In Northern Ireland during 2011/12: 
 
 2,999 individuals presented for treatment and gave their 
consent for their details to be included in the DMD. This is 
compared with 2,593 in 2010/11, an increase of 406 
individuals (16%). 
 
 The majority (75%) of individuals who presented were 
male; and just under one quarter (24%) were aged 21 years 
and under.   
 
 Cannabis was the most commonly reported main drug of 
misuse; it was reported by 41% of individuals in 2011/12 
compared with 40% in 2010/11. 
 
 Benzodiazepines were the second most commonly 
reported main drug of misuse; they were reported by 24% 
of individuals in 2011/12 compared with 19% in 2010/11. 
 
 Both other opiates and cocaine were the third most 
commonly reported main drugs of misuse; each reported 
by 7% of individuals in 2011/12.  
 
 Heroin was reported as the main drug of misuse by 6% of 
individuals in 2011/12 compared with 7% in 2010/11. Of 
those who presented for treatment in 2011/12 and reported 
heroin as their main problem drug, 55% had been treated 
before. 
 
 The proportion of individuals who had ever injected was 
7% in 2011/12, compared with 8% in 2010/11. 
 
 
 
_____________________ 
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1.  Introduction  
1.1 In 1995, the Northern Ireland Drugs 
Policy Statement highlighted the need for a 
centralised database on drug misuse in 
Northern Ireland. The then Department of 
Health and Social Services (DHSS) 
subsequently commissioned a feasibility 
study that considered the experience 
elsewhere (databases already existed in 
Scotland, Wales, and regionally in England), 
data availability, and data quality in 
Northern Ireland and took due account of 
issues of confidentiality. The study found 
that the majority of agencies were 
supportive of the idea of a drug misuse 
database and identified a number as 
potential providers. 
 
1.2 Subsequently the Northern Ireland 
Drug Misuse Database (DMD) was 
established and data collection commenced 
from April 2000.  The database is 
maintained by the Public Health Information 
and Research Branch (PHIRB) located 
within the Department of Health, Social 
Services, and Public Safety (DHSSPS).   
 
1.3 The New Strategic Direction for 
Alcohol and Drugs 2006-2011 was launched 
in October 2006.  As a result the nature of 
the service provided by some treatment 
services changed to meet the needs outlined 
in the strategy.  The NSD was reviewed, 
revised and extended and in December 2011 
the New Strategic Direction for Alcohol   
and Drugs: Phase 2 - 2011-2016, was 
launched.   
 
1.4 This is the eleventh bulletin to be 
published using data from the DMD and 
covers the period 1 April 2011 – 31 March 
2012. By the end of 2011/12, 43 treatment 
services were contributing to the database of 
which 19 were non-statutory, 20 were 
statutory and 4 services were based within 
prisons. It is important to note that more 
than one treatment service may be 
represented by the same organisation, for 
example, where an organisation has services 
in more than one location, and across Health 
and Social Care Trusts. In addition, while a 
client might present for treatment to services 
based within the prisons, this does not mean 
that the client is using drugs whilst in 
custody.   
 
1.5 The DMD collects information on 
problem drug users presenting to services 
for the first time, or for the first time in six 
months or more, and who will receive 
treatment at the agency. A problem drug 
user is defined as a person who experiences 
social, psychological, physical or legal 
problems (related to intoxication and/or 
regular excessive consumption and/or 
dependence) as a consequence of their own 
use of drugs or chemical substances. Drugs 
are defined as any drug, whether prescribed 
or not, including solvents and tranquillisers 
but excluding alcohol and tobacco. The data 
are collected from drug treatment agencies 
and include selected personal details and 
information regarding the drugs misused and 
the type of agency attended: these data are 
passed on in an anonymised form to PHIRB 
for inclusion in the DMD. As provision of 
information to the DMD requires client 
consent, in a number of cases consent was 
withheld and full information relating to 
these clients has not been included in the 
DMD (Table 1). 
 
1.6 The aim of the DMD is to provide 
high-quality, consistent information on the 
numbers and profiles of presenting problem 
drug users to inform both policy and 
practice. The database will be kept under 
review. 
 
Compliance Exercise 
1.7 In 2011, a compliance exercise was 
in progress to improve completion and 
return of DMD forms. It is important to 
consider this when comparing the numbers 
presenting to treatment services in 2011/12 
with previous years, as any increase can be 
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partly explained by the compliance exercise 
and thus it may not be entirely an increase in 
the number of individuals presenting to 
treatment services. 
 
Other Information Available 
1.8 It is important to note that this report 
does not provide information on the overall 
size and nature of problem drug use or 
misuse in Northern Ireland. Other research 
commissioned and published by PHIRB 
complements this DMD bulletin.  All 
PHIRB publications are available online at: 
http://www.dhsspsni.gov.uk/index/stats_resear
ch/stats-public-health/stats-drug-alcohol.htm 
 
Participation in the DMD 
1.8 Client participation in the DMD 
depends on client consent. Information was 
received from 3,123 clients who presented 
for treatment, and client consent was 
withheld in 124 (4%) cases (Table 1).  All 
figures in this report are based on the 2,999 
clients who gave their consent to be 
included in the DMD. 
 
2. Profile of service users 
Age and Gender of Clients 
2.1 Three quarters (75%) of clients who 
presented for treatment were male (Table 2). 
This is similar to the gender split found in 
England where the majority (73%) of treated 
persons were male (Source: National 
Treatment Agency for Substance Misuse 
‘Statistics from the National Drug Treatment 
Monitoring System (NDTMS), 1 April 2010 
– 31 March 11’).      
 
2.2 The average (mean) age of clients 
who presented for treatment was 32 years.  
The greatest proportion of those presenting 
for treatment were aged 22-29 years (28%) 
followed by those aged 40 years and over 
(26%). Just under one quarter were aged 21 
years and under (24%) while 23% were aged 
30-39 years (Table 3).  
 
2.3 The age profile for female clients 
was older than that for male clients: Over 
one half (52%) of female clients compared 
with 17% of male clients were aged 40 years 
and over, while over one quarter (27%) of 
male clients were aged 21 years or under, 
compared with 14% of female clients (Table 
4; Figure 1). 
Figure 1. Age and gender of clients that 
presented for treatment: 2011/12
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2.4 Approximately two fifths (41%) of 
clients presented for treatment in the Belfast 
Health and Social Care Trust (HSCT), 14% 
in the South Eastern HSCT, 11% in the 
Western HSCT, 8% in the Southern HSCT 
and 4% in the Northern HSCT (Table 1). It 
should be noted that these figures are based 
on where people presented for treatment, 
and not their place of residence. Data on 
place of residence for those registered on the 
DMD are incomplete, as only 5-figure 
postcodes are available, and in some 
instances postcode data are missing or 
erroneous. For clients whose area of 
residence could be determined and 
excluding those who were being treated in 
prison, 88% lived in the same HSCT as they 
were treated in. This suggests that HSCT of 
treatment is a reasonable proxy for HSCT of 
residence. 
 
2.5 The incidence of treatment per 
100,000 population was higher in the Belfast 
HSCT (356 per 100,000 population) than in 
the South Eastern, Western, Southern and 
Northern HSCTs (124, 108, 68 and 28 per 
100,000 population, respectively) (Figure 2). 
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Type of Treatment Service Agency 
2.6 Over three fifths of clients (63%) 
presented for treatment at statutory agencies. 
The majority of clients in each of the five 
HSCTs presented for treatment at statutory 
agencies, varying from 79% in the South 
Eastern HSCT to 51% in the Belfast HSCT 
(Table 5). 
 
3. Referral Details 
Reason for attendance 
3.1 Almost one half of clients (47%) 
reported that they were required by others to 
attend treatment, while 37% reported that 
their decision to attend was wholly their 
own choice and 16% were persuaded by 
others (Table 6).   
 
3.2 The three most commonly reported 
reasons for attending a treatment agency 
were psychological (41%), family/ 
relationships (38%) and legal (36%). Other 
reasons included medical e.g. detoxification 
(27%), financial (8%), job (7%) and housing 
(4%) (Table 6).   
 
Referral Source 
3.3 Two fifths (40%) of clients who 
presented for treatment were referred by a 
General Practitioner, followed by Prison/ 
Young Offenders Centre (20%). Other 
sources of referral included self-referral 
(11%), probation services (6%), psychiatrist/ 
mental health service (4%), social services 
(3%), and family/friend (2%) (Table 7).   
 
 
Proposed Action 
3.4 The agency reporter must record all 
actions which they propose to take/initiate, 
or have taken, in respect of the client. 
Counselling was proposed for over half of 
clients (54%), while education/information 
was proposed for just under half of clients 
(47%). Both detoxification and mentoring 
were a proposed action for 14% of clients 
(Table 8), while advised screening for HIV, 
Hep B or C was proposed for 5% of clients.  
 
4. Drugs of Misuse 
Background 
4.1 Clients must record one main 
problem drug; this is the drug which is 
causing the client the most problems at the 
time they presented for treatment.  They also 
have an option to record a further four 
subsidiary drugs of misuse. Figure 3 shows 
the number of drugs clients reported 
misusing. Over two fifths (43%) of clients 
reported misusing only one drug, while over 
one quarter (27%) reported misusing two 
drugs.  Seven per cent of clients reported 
misusing five drugs. 
Figure 3. Number of drugs misused per 
client: 2011/12
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Main Drug of Misuse 
4.2 The most frequently reported main 
drug of misuse was cannabis, accounting for 
two fifths (41%) of clients who presented 
for treatment, followed by benzodiazepines 
(24%). This was followed by cocaine 
(including crack cocaine) and other opiates 
(each 7%) while heroin was the main 
Total: 2,999 
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Figure 2. Rates per 100,000 population 
presenting for treatment in HSCT: 2011/12
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problem drug for 6% of clients (Table 9; 
Figure 4).  
Figure 4. Main drugs of misuse: 2011/12
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4.3 There was considerable variation 
between male clients and female clients in 
the main drug of misuse reported (Table 9). 
Almost one half (48%) of male clients 
reported that cannabis was their main 
problem drug, compared with just under one 
fifth (18%) of female clients. In addition, 
8% of male clients compared with 3% of 
female clients reported cocaine (including 
crack cocaine) as their main problem drug. 
In contrast, a larger proportion of female 
clients (45%) than male clients (16%) 
reported benzodiazepines as their main 
problem drug, and 8% of female clients 
compared with 2% of male clients reported 
other hypnotics as their main problem drug.  
 
4.4 There was also variation between the 
client’s age group and the main drug of 
misuse reported (Table 10). As in previous 
years, cannabis was the most commonly 
reported main problem drug by clients in 
both the under 18 years and 18-25 years  age 
groups, while for clients aged 26 years and 
over benzodiazepines were the most 
commonly reported main problem drug.  For 
clients aged under 18, almost four fifths 
(78%) reported cannabis; 9% reported 
mephedrone/methedrone; and 6% reported 
solvents as their main problem drug.  For 
clients aged 18-25 almost three fifths (58%) 
reported cannabis; 12% reported 
benzodiazepines; 7% reported methedrone/ 
mephedrone, and 6% reported other opiates 
as being their main problem drug.  For 
clients aged 26 years and over, 
approximately one third (32%) reported 
benzodiazepines as their main problem drug. 
Following this, the most commonly reported 
main problem drug for those aged 26 years 
and over was cannabis (28%), other opiates 
(9%), cocaine (including crack cocaine) 
(7%), and heroin (7%). 
 
4.5 The average (mean) age clients first 
used their main problem drug was 23 years.  
Almost one half (47%) reported first using 
their main problem drug before the age of 18 
years, while 16% reported first using it 
between 18 and 21 years. Fourteen per cent 
of clients reported first using their main 
problem drug aged between 22 and 29 years, 
and almost one quarter (23%) reported first 
using it aged 30 years and over (Figure 5).  
Figure 5. Age of first use: main drug of misuse: 
2011/12*
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4.6 There was considerable variation in 
age of first use and main problem drug 
reported. The lowest average (mean) age of 
first use was for solvents (13 years) and 
cannabis (15 years). The highest average 
(mean) age of first use was for other 
hypnotics (38 years) and benzodiazepines 
(33 years) (Figure 6). 
Total: 2,999 
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Figure 6. Average (mean) age of first use of 
main problem drug: 2011/12
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4.7 Cannabis was the most frequently 
reported main problem drug by clients in 
four of the five HSCTs. In the Western 
HSCT 64% reported their main problem 
drug as being cannabis, followed by 56% in 
the Southern HSCT, 42% in the Northern 
HSCT, and 36% in the Belfast HSCT. The 
most frequently reported main problem drug 
in the South Eastern HSCT was 
benzodiazepines (44%), followed by 
cannabis (28%). The Northern HSCT had 
the largest proportion of clients (20%) 
reporting heroin as their main problem drug. 
The Southern HSCT had the largest 
proportion of clients reporting cocaine 
(including crack cocaine) (8%) and 
mephedrone/ methedrone (13%) as their 
main problem drug (Table 11).  
 
All drugs of misuse    
4.8 Clients presenting for treatment may 
have more than one drug of misuse.  The 
DMD can record up to a total of five drugs 
of misuse, one main problem drug and four 
subsidiary drugs.  Over seven tenths (1,227 
of 1,733 clients; 71%) of clients who 
reported cannabis as a problem drug 
reported it as their main problem drug 
(Tables 11 & 12).  Similarly, of those who 
reported heroin as a problem drug, over four 
fifths (174 of 227 clients; 77%) reported it 
as their main drug of misuse. Just over half 
(705 of 1,254 clients; 56%) of those who 
reported benzodiazepines as a problem drug 
reported it as their main problem drug, while 
50% (219 of 442 clients) of those reporting 
other opiates as a problem drug reported it 
as their main problem drug.  In contrast, a 
smaller proportion of clients (55 of 426 
clients; 13%) who reported ecstasy as a 
problem drug reported it as their main drug 
of misuse.   
 
4.9 The most commonly reported drug 
of misuse was cannabis, with almost three 
fifths (58%) of clients reporting it as a 
problem drug. Benzodiazepines was the 
second most commonly reported drug of 
misuse (42%), although it should be noted 
that the majority of clients presenting to 
treatment for these drugs were in the Belfast 
and South Eastern HSCTs where 
benzodiazepine projects exist (53% and 
70%, respectively).  The third most 
commonly reported problem drug was 
cocaine (including crack cocaine) (24%) 
followed by mephedrone/methedrone and 
other opiates (each 15%), and ecstasy 
(14%).  
 
All drugs of misuse by Trust 
4.10 There were some variations across 
the HSCTs and the reported drugs of misuse. 
A majority of clients in the South Eastern 
HSCT (70%) and 53% in the Belfast HSCT 
reported benzodiazepines as a problem drug, 
compared with 32% of clients in the 
Northern HSCT, 14% in the Western HSCT 
and 13% in the Southern HSCT. Cannabis 
was the most commonly reported drug by 
clients in the Western (80%), Southern 
(67%) and Northern (60%) HSCTs.  In the 
South Eastern HSCT cannabis was the 
second most commonly reported drug of 
misuse, reported by 40% of clients. 
Mephedrone/methedrone was the second 
most commonly reported drug in the 
Western and Southern HSCTs (each 36%). 
(Table 12).       
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 Reported use of alcohol 
4.11 Alcohol cannot be recorded as the 
main problem drug or as one of the four 
subsidiary drugs on the DMD.  However, 
clients can still record problem alcohol use, 
the average units consumed per week in the 
last 4 weeks and whether or not alcohol is 
their main problem.  
 
4.12 Of the 2,999 individuals who presented 
for treatment, 38% reported problem alcohol 
use (Table 13).  The largest proportions of 
clients who reported problem alcohol use 
were in the Southern (65%), Western (55%) 
and South Eastern (50%) HSCTs. Just over 
half (52%) of those that presented to 
treatment for both drug and alcohol misuse 
reported alcohol as being their main 
problem.  
 
4.13 Of those who reported problem alcohol 
use, almost one half (46%) reported that 
they consumed between 1 and 99 units of 
alcohol on average per week in the four 
weeks before treatment.  One fifth (20%) 
reported that they consumed between 100 
and 249 units (Table 14).    
 
5. Treatment History 
5.1 Approximately one quarter (24%) of 
clients who presented to treatment in 
2011/12 had previously been treated for 
drug misuse (Table 15).  
 
5.2 There was some variation between 
the treatment history of clients and their 
main drug of misuse: 55% of clients who 
reported heroin, 41% of clients who reported 
other drugs, 35% of clients who reported 
ecstasy, and 34% of clients who reported 
other opiates and cocaine as their main 
problem drug, had been treated before. 
Smaller proportions of clients who reported 
benzodiazepines (11%), and other hypnotics 
(8%) as their main problem drug had been 
treated before.   
 
 5.3 There was some variation in 
treatment history between the four most 
commonly reported main problem drugs and 
age group (Figure 7).  The proportion of 
clients who reported benzodiazepines as 
their main problem drug and had been 
treated before differed; 25% of those aged 
22-25 years, compared with 20% of those 
aged 26-29 years and 21% of those aged 30-
39 years had been treated before.  
 
 For those who reported cannabis as their 
main problem drug, the proportion of clients 
who had been treated before ranged from 
19% of those aged 22-25, to 30% of those 
aged 30-39 years.  
 
For those who reported other opiates as their 
main problem drug, the proportion of clients 
who had been treated before ranged from 
15% of those aged 22-25 years to 37% of 
those aged 26-29 years, and 36% of those 
aged 30-39 years.  
 
For those who reported cocaine as their 
main problem drug, the proportion of clients 
who had been treated before ranged from 
18% of those aged 22-25 years and 21% of 
those aged 26-29 years to 41% of those aged 
30-39 years.  
Figure 7. Percentage of clients 
previously treated for selected drugs 
and age groups: 2011/12
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5.4 Of the clients who had previously 
been treated and whose age at first treatment 
was known (626 clients), almost one half 
(47%) were first treated aged 26 years and 
over, approximately two fifths (38%) were 
first treated aged 18-25 years and 15% were 
aged under 18 years (Table 16).   
 
6.  Injecting and Sharing Behaviour 
 
Injecting Behaviour 
6.1 Data regarding a client’s injecting 
behaviour are collected in two different 
ways. The most frequent route of 
administration for each drug of misuse is 
recorded; and another question asks clients 
if they have ever injected any drug (injecting 
history). 
  
6.2 Injecting was reported as the main 
route of administration by 123 clients (4%).  
Other main routes of administration were: 
oral (45%), smoking/inhalation (40%), and 
sniffing (11%) (Table 17).  
 
6.3 The injecting history was known for 
2,957 of the 2,999 clients (99%) who 
presented for treatment. Seven per cent (218 
clients) of clients with a known injecting 
history reported that they had injected at 
some time in their lives (Table 18).  The 
proportion of clients with a known injecting 
history that had injected varied across the 
five HSCTs: approximately one quarter 
(24%) in the Northern HSCT, compared 
with 9% in the Western HSCT, 6% in both 
the Belfast and Southern HSCTs and 5% in 
the South Eastern HSCT.  
 
6.4 The age clients first injected was 
available for 208 of the 218 clients who had 
injected (injectors) (Table 19). Of these, 
38% first injected at 18-21 years of age. A 
further 35% of injectors first injected aged 
22-29 years. Nine per cent first injected at 
30-39 years while 14% were under 18 years 
of age.  
 
 
Sharing Equipment 
6.5 The Department of Health, in their 
statistical publications on regional DMDs, 
suggest that reliance on a single question 
about sharing behaviour is likely to produce 
an underestimate of true sharing behaviour. 
The Northern Ireland DMD also uses a 
single question to elicit information about 
sharing behaviour, and thus the results 
quoted in this bulletin should be treated as 
minimum estimates. This question is only 
asked of those who have injected. 
 
6.6 Information about the sharing of 
drug paraphernalia is known for 210 clients 
who had injected (Table 20), of which 
approximately three tenths (31%) reported 
sharing equipment.  This was 35% for 
females and 31% for males. 
 
7. Viral Testing 
7.1   The DMD records if clients 
presenting for treatment have previously 
been tested for HIV, Hepatitis B, and 
Hepatitis C.  
 
7.2 Table 21(a) shows that 92% of 
clients who presented for treatment had 
never been tested for HIV, 6% had ever 
been tested and 2% had been tested in the 
last 12 months. 
 
7.3 Table 21(b) shows that 92% of 
clients who presented for treatment had 
never been tested for Hepatitis B, 6% had 
ever been tested and 2% had been tested in 
the last 12 months.   
 
7.4 Table 21(c) shows that 92% of 
clients who presented for treatment had 
never been tested for Hepatitis C, 6% had 
ever been tested and 2% had been tested in 
the last 12 months.     
 
7.5 96% of clients had not received any 
injections of the Hepatitis B vaccination 
course, 3% had completed all three 
injections, and 1% had started the 
vaccination course but not yet completed it.  
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The Northern HSCT had the smallest 
proportion of clients who had not had any 
injections of the Hepatitis B vaccination 
(83%). All other Trusts had between 96-
98% of clients who had not received any 
injections of the Hepatitis B vaccination 
(Table 22).  
 
 
8. Other Information 
8.1 Some background information on 
clients who presented for treatment is given 
in Tables 23-26.  
 
Living Arrangements 
8.2 The greatest proportion of clients 
reported living alone (24%), followed by 
22% who reported living in Prison/YOC. 
Around one fifth (21%) reported living with 
parents while 9% lived with spouse/partner 
and children, and 8% lived with 
spouse/partner only. Four per cent of clients 
were living with dependent children only.  
One hundred and seventy one (6%) reported 
living with other drug users (Table 23). 
 
Employment Status 
8.3 Thirteen percent of clients who 
presented for treatment were in employment 
at the time of presenting and almost three 
tenths of clients (28%) reported having 
worked in the 12 months before treatment 
commenced. Under one half (46%) of 
clients were unemployed and 9% were 
receiving other benefits. Five per cent of 
clients were students, while 4% were 
retired/receiving pension (Table 24).   
 
EU Nationality 
8.4 The vast majority (98%) of clients 
were EU nationals (Table 25).   
 
Legal Status 
8.5 It should be noted that clients can 
fall into more than one legal status category, 
and so percentages may not total 100. The 
majority of individuals (57%) reported no 
contact with the criminal justice system. Just 
over one fifth (22%) of individuals were in 
prison, 8% were under community 
supervision and 6% had a trial pending.  
Others clients reported their legal status as 
arrest referral (5%), awaiting sentence (2%) 
and deferred sentence (1%) (Table 26).  
 
9. Comparisons: 2010/11 to 2011/12 
9.1 In 2011/12, 2,999 clients presented 
for treatment compared with 2,593 clients in 
2010/11, an increase of 406 clients or 16% 
(Table C1).  
 
Age of Clients 
9.2 The age profile of clients who 
presented for treatment in 2011/12 was 
similar to that in 2010/11.  The proportion of 
clients aged 21 years and under was 27% in 
2010/11 compared with 24% in 2011/12. 
The proportion of clients aged 22-29 years 
was 27% in 2010/11 compared with 28% in 
2011/12, while the proportion of clients 
aged 30 years and over was 46% in 2010/11 
compared with 48% in 2011/12 (Table C1).   
 
9.3 In the Belfast HSCT the proportion 
of clients aged under 18 years was 4% in 
2010/11 compared with 5% in 2011/12. The 
proportion of clients aged 18-25 years was 
32% in 2010/11, compared with 27% in 
2011/12. The proportion of clients aged 26 
years and over was 64% in 2010/11 
compared with 68% in 2011/12 (Table 
C2(a)).   
 
9.4 In the Northern HSCT the proportion 
of clients aged under 18 years was 38% in 
2010/11 compared with 27% in 2011/12. 
The proportion of clients aged 18-25 years 
was 23% in 2010/11 compared with 26% in 
2011/12, while the proportion of clients 
aged 26 years and over was 39% in 2010/11 
compared with 47% in 2011/12 (Table 
C2(b)).   
 
9.5 In the South Eastern HSCT the 
proportion of clients aged under 18 years 
was 5% in 2010/11, compared with 7% in 
2011/12. The proportion of clients aged 18-
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25 years was 25% in 2010/11 compared 
with 20% in 2011/12 and the proportion of 
clients aged 26 years and older was 70% in 
2010/11 compared with 73% in 2011/12 
(Table C2(c)). 
 
9.6 In the Southern HSCT, the 
proportion of clients aged under 18 years 
was 22% in 2010/11, compared with 19% in 
2011/12. The proportion of clients aged 18-
25 years was 29% in 2010/11 compared 
with 26% in 2011/12 and the proportion of 
clients aged 26 years and over was 49% in 
2010/11 compared with 55% in 2011/12 
(Table C2(d)).   
 
9.7 In the Western HSCT the proportion 
of clients aged under 18 years was 15% in 
2010/11 compared with 12% in 2011/12. 
The proportion of clients aged 18-25 years 
was 37% in 2010/11 compared with 38% in 
2011/12, whereas the proportion of clients 
aged 26 years and over was 49% in 2010/11 
and 50% in 2011/12 (Table C2(e)).    
 
Main Problem Drug 
9.8 In both 2010/11 and 2011/12 
cannabis was the most commonly reported 
main drug of misuse; the proportion of 
clients reporting it as their main problem 
drug was 40% in 2010/11 compared with 
41% in 2011/12. Similarly, benzodiazepines 
was the second most commonly reported 
main problem drug in both 2010/11 and 
2011/12; the proportion of clients reporting 
it as their main problem drug was 19% in 
2010/11 compared with 24% in 2011/12. 
The proportion of clients who reported 
cocaine (including crack cocaine) as their 
main problem drug was 6% in 2010/11 
compared with 7% in 2011/12, while the 
proportion of clients reporting heroin as 
their main problem drug was 7% in 2010/11 
compared with 6% in 2011/12. (Table C3).     
 
9.9 In the Belfast HSCT, the proportion 
of clients who presented for treatment with 
cannabis as their main problem drug was 
38% in 2010/11 compared with 36% in 
2011/12.  The proportion of clients who 
reported benzodiazepines as their main 
problem drug was 26% in 2010/11 
compared with 33% in 2011/12 (Table 
C4(a)).  
 
9.10 In the Northern HSCT, the 
proportion of clients who reported cannabis 
as their main problem drug was 42% in both 
2010/11 and 2011/12, while the proportion 
of clients who reported heroin as their main 
problem drug was 24% in 2010/11 
compared with 20% in 2011/12. The 
proportion of those reporting other opiates 
as their main problem drug was 10% in 
2010/11 compared with 15% in 2011/12 
(Table C4 (b)). 
 
9.11 In the South Eastern HSCT, the 
proportion of clients who reported cannabis 
as their main problem drug was 27% in 
2010/11 compared with 28% in 2011/12, 
while the proportion of clients who reported 
benzodiazepines as their main problem drug 
was 32% in 2010/11 compared with 44% in 
2011/12 (Table C4(c)).   
 
9.12 In the Southern HSCT, the 
proportion of clients who reported cannabis 
as their main problem drug was 47% in 
2010/11 compared with 56% in 2011/12, 
while the proportion of clients who reported 
other opiates as their main problem drug 
was 4% in 2010/11 compared with 6% in 
2011/12. The proportion of clients reporting 
heroin as their main problem drug was 15% 
in 2010/11 compared with 6% in 2011/12 
(Table C4(d)).   
 
9.13 In the Western HSCT, the proportion 
of clients who reported cannabis as their 
main problem drug was 55% in 2010/11 
compared with 64% in 2011/12. (Table 
C4(e)).   
 
Injecting Behaviour  
9.14 The proportion of clients who 
reported they had injected was 8% in 
2010/11, compared with 7% in 2011/12. The 
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largest proportion of clients who had 
injected was in the Northern HSCT where 
28% had injected in 2010/11 compared with 
24% in 2011/12.  The proportion of clients 
who had injected in the Western HSCT was 
3% in 2010/11 compared with 9% in 
2011/12.  In the Southern HSCT the 
proportion of clients who had injected was 
13% in 2010/11 compared with 6% in 
2011/12. The proportion of those who had 
injected in the Belfast and South Eastern 
HSCTs remained similar in both years. 
(Table C5). 
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presented in this bulletin – particularly the 
agencies who have collected and sent in 
data, and clients who presented for treatment 
for providing the information and allowing it 
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11. Editorial Notes 
11.1 Data were first collected for the 
DMD in Northern Ireland from 1 April 
2000.  The DMD was in a development 
stage in 2000/01, and data from that year are 
not suitable for publication.  
 
11.2 This report is based on information 
received for 2011/12 up to and including 20 
August 2012. 
  
11.3 Percentages do not always add to 
100 due to rounding. 
 
11.4 Client’s age is their age on their first 
face to face contact with treatment agency.      
 
11.5 From the 1
 
April 2007 new 
procedures were implemented regarding the 
disclosure of information in publications.  
Any cell within a table that has a value of 
less than five (excluding zeros) has not been 
presented, while other cells have been 
masked to prevent the value in another cell 
from being calculated. This is to ensure 
individuals cannot be identified.     
 
11.6 Any comments or questions 
concerning the data contained in this 
publication, or requests for further 
information, should be addressed to: 
 
PHIRB 
Annex 2 
Castle Buildings 
Stormont 
Belfast BT4 3SQ 
Telephone: 028 9052 2509 
Fax: 028 90 52 3288 
E-mail: PHIRB@dhsspsni.gov.uk 
 
11.7 Further copies of this publication can 
be obtained on-line at: 
http://www.dhsspsni.gov.uk/index/stats_rese
arch/stats-public-health/stats-drug-
alcohol.htm 
Many other statistical and research reports 
from the Department of Health, Social 
Services and Public Safety’s Information 
and Analysis Directorate are available at this 
web address.  
 
The Northern Ireland Statistics and 
Research Agency 
11.8 The Northern Ireland Statistics and 
Research Agency (NISRA) is the principal 
source of official statistical information 
about Northern Ireland. Further information 
is available from the NISRA website at 
www.nisra.gov.uk or via e-mail at 
info.nisra@dfpni.gov.uk.  
 
 
Future Publications 
11.9 This DMD publication will be 
updated on an annual basis. The next DMD 
Statistical Bulletin will be published on 
Thursday 3rd October 2013. 
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ANNEX A – MAP  
 
Map showing summary statistics for each Health and Social Care Trust (1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Crown Copyright © 2012 
 
(1)
 This map excludes returns received from prisons. 
 
(2) 
The services available across all Trust areas vary and this may be reflected in the main drugs of 
misuse. For example, in areas where benzodiazepine projects exist, there are greater proportions of 
individuals presenting to services with benzodiazepine misuse, than in areas where no such projects 
exist. 
Western HSCT 
Number of clients:      318 (11%)  
Number of clients reporting main drug to be: 
 Cannabis      204 (64%) 
 Mephedrone/Methedrone   30 (9%) 
 Other Opiates     21 (7%) 
 Cocaine      15 (5%) 
 Benzodiazepines     9 (3%) 
Mean age of clients:      28 
Number of clients ever injected:     28 (9%) 
  
Northern HSCT 
Number of clients:      129 (4%) 
Number of clients reporting main drug to be: 
 Cannabis      54 (42%) 
 Heroin      26 (20%) 
 Other Opiates     19 (15%) 
 Benzodiazepines     11 (9%) 
Mean age of clients:      27 
Number of clients ever injected:     31 (24%) 
 
South Eastern HSCT 
Number of clients:          430 (14%) 
Number of clients reporting main drug to be: 
 Benzodiazepines        191 (44%) 
 Cannabis           122 (28%)           
 Other Opiates           32 (7%) 
 Cocaine        16 (4%)       
 Mephedrone/Methedrone     16 (4%) 
Mean age of clients:           39 
Number of clients ever injected:       21 (5%) 
  
Southern HSCT 
Number of clients:         243 (8%) 
Number of clients reporting main drug to be: 
 Cannabis        135 (56%) 
 Mephedrone/Methedrone       31 (13%) 
 Cocaine (2)          19 (8%) 
 Heroin          15 (6%) 
 Other Opiates         15 (6%) 
Mean age of clients:        29 
Number of clients ever injected:       14 (6%) 
 
Belfast HSCT 
Number of clients:     1,239 (41%) 
Number of clients reporting main drug to be: 
 Cannabis      442 (36%) 
 Benzodiazepines     407 (33%) 
 Cocaine      73 (6%) 
 Other Opiates     60 (5%) 
Mean age of clients:      35 
Number of clients ever injected:     74 (6%) 
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Total number of DMD forms received from each HSCT: 
2011/12 
 
Gender of clients who presented for treatment by HSCT: 
2011/12 
 
Age of clients who presented for treatment by HSCT: 2011/12 
 
 
Age and gender of clients who presented for treatment: 
2011/12 
 
Agency type of clients who presented for treatment in each 
HSCT: 2011/12 
 
Reasons clients reported for attending treatment services: 
2011/12 
 
Referral details of clients who presented for treatment: 
2011/12 
 
Proposed action of treatment for clients who presented for 
treatment: 2011/12 
 
Main drug of misuse of clients who presented for treatment by 
gender: 2011/12 
 
Main drug of misuse of clients who presented for treatment by 
age: 2011/12 
 
Main drug of misuse of clients who presented for treatment by 
HSCT: 2011/12 
 
All drugs of misuse of clients who presented for treatment by 
HSCT: 2011/12 
 
Problem alcohol use by HSCT: 2011/12 
 
Average units of alcohol consumed per week in the four weeks 
before treatment: 2011/12 
 
Treatment history of clients who presented for treatment by 
main drug of misuse: 2011/12 
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Table 16 
 
 
Table 17 
 
 
Table 18 
 
 
Table 19 
 
 
Table 20 
 
 
Table 21 
 
 
Table 22 
 
 
Table 23 
 
 
Table 24 
 
 
Table 25 
 
 
Table 26 
Age profile of clients at their current treatment, and at their 
first treatment: 2011/12 
 
Route of administration for main drug of misuse by clients 
who presented for treatment: 2011/12 
 
Injecting history of clients who presented for treatment by 
HSCT: 2011/12 
 
Age first injected of clients who presented for treatment who 
had ever injected: 2011/12 
 
Gender of injectors who presented for treatment by sharing 
history: 2011/12 
 
Number of clients who have previously been tested for HIV, 
Hepatitis B and C: 2011/12 
 
Number of injections clients have completed for the Hepatitis 
B Vaccination Course by HSCT: 2011/12 
 
Living arrangements of clients who presented for treatment: 
2011/12 
 
Employment status of clients who presented for treatment: 
2011/12 
 
EU nationality of clients who presented for treatment: 2011/12 
 
 
Legal status of clients who presented for treatment: 2011/12 
31 
 
 
32 
 
 
33 
 
 
34 
 
 
34 
 
 
35-36 
 
 
37 
 
 
38 
 
 
38 
 
 
39 
 
 
39 
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Table 1.  Total number of DMD forms received from each HSCT: 2011/12 
 
         numbers and percentages 
 
HSCT
(1) 
Total number of 
forms received
(2)
 
Number of consent 
withheld forms 
received
(3)
 
Number of forms 
analysed
(4)
 
    
Belfast 1,334 95 1,239 
Northern - - 129 
South Eastern - - 430 
Southern - - 243 
Western 318 0 318 
    
Prisons 640 0 640 
    
Total 3,123 124 2,999 
    
    
    
Percentages    
    
Belfast 43 77 41 
Northern - - 4 
South Eastern - - 14 
Southern - - 8 
Western 10 0 11 
    
Prisons 20 0 21 
    
Total 100 100 100 
 
 
 
(1)
 A complete HSCT has not been presented as some cells were masked to hide counts of less than five and 
some (with cell counts of more than five) to prevent the value in another cell from being calculated; this is to 
ensure individuals cannot be identified.  These cells have been marked „-„. 
 
(2) 
A DMD form is completed for every problem drug user who presents at an Agency for treatment.  This covers 
only those problem drug users attending the Agency for the very first time, or for those who have not attended the 
Agency within the previous six months.  They must present with a drug related problem. 
 
(3)
 The provision of information to the database requires client consent. Where consent is not given a blank form 
is returned with „consent withheld‟ written across it, along with the designated Agency code. 
 
(4) 
All data in this statistical bulletin are based on an analysis of DMD forms where consent is given. 
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Table 2.   Gender of clients who presented for treatment by HSCT: 2011/12 
 
            numbers and percentages 
 
HSCT Male Female Total 
    
Belfast 832 407 1,239 
Northern 99 30 129 
South Eastern 250 180 430 
Southern 209 34 243 
Western 235 83 318 
    
Prison 627 13 640 
    
Total 2,252 747 2,999 
 
 
 
 Percentages 
 
Belfast 67 33 100 
Northern 77 23 100 
South Eastern 58 42 100 
Southern 86 14 100 
Western 74 26 100 
    
Prison 98 2 100 
    
Total 75 25 100 
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Table 3.   Age of clients who presented for treatment by HSCT: 2011/12 
 
          numbers and percentages 
 
HSCT  Under 
18 years 
18-21 
years 
22-25 
years 
26-29 
years 
30-39 
years 
40 years 
& over 
Total 
        
Belfast 58 165 171 139 278 428 1,239 
Northern 35 18 16 12 34 14 129 
South Eastern 32 43 43 38 89 185 430 
Southern 46 29 34 39 52 43 243 
Western 39 76 44 34 76 49 318 
        
Prison 7 170 143 123 147 50 640 
        
Total  217 501 451 385 676 769 2,999 
 
 
 
Percentages 
 
Belfast 5 13 14 11 22 35 100 
Northern 27 14 12 9 26 11 100 
South Eastern 7 10 10 9 21 43 100 
Southern 19 12 14 16 21 18 100 
Western 12 24 14 11 24 15 100 
        
Prison 1 27 22 19 23 8 100 
        
Total 7 17 15 13 23 26 100 
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Table 4.   Age and gender of clients who presented for treatment: 2011/12 
 
         numbers and percentages 
 
Age group Male Female Total 
    
Under 18 years 181 36 217 
18-21 years 433 68 501 
22-25 years 388 63 451 
26-29 years 338 47 385 
30-39 years 530 146 676 
40 years & over 382 387 769 
    
Total  2,252 747 2,999 
 
 
 
Percentages 
 
Under 18 years 8 5 7 
18-21 years 19 9 17 
22-25 years 17 8 15 
26-29 years 15 6 13 
30-39 years 24 20 23 
40 years & over 17 52 26 
    
Total 100 100 100 
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Table 5.   Agency type of clients who presented for treatment in each HSCT: 
2011/12 
 
         numbers and percentages 
 
HSCT 
(1)
 Non-Statutory Statutory Total 
    
Belfast 609 630 1,239 
Northern 39 90 129 
South Eastern 91 339 430 
Southern 57 186 243 
Western 88 230 318 
    
Total 884 1,475 2,359 
 
 
 
Percentages 
 
Belfast 49 51 100 
Northern 30 70 100 
South Eastern 21 79 100 
Southern 23 77 100 
Western 28 72 100 
    
Total 37 63 100 
 
(1)
 Returns from Prisons are excluded from this analysis.
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Table 6.  Reasons clients reported for attending treatments services: 2011/12 
 
            numbers and percentages 
 
Reason for attendance Number % 
   
Wholly own choice 1,105 37 
Persuaded by others 490 16 
Required by others 1,404 47 
   
Total 2,999 100 
   
   
Reasons for attending: 
(1)
   
Financial 254 8 
Legal 1,085 36 
Job 212 7 
Family/Relationships 1,153 38 
Medical e.g. detoxification 809 27 
Psychological 1,220 41 
Housing 115 4 
Pregnancy 15 1 
Not Known 10 0 
Other 42 1 
   
 
(1)
 Individuals can report more than one reason for attending treatment; percentages do not total to 
100. 
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Table 7.   Referral details of clients who presented for treatment: 2011/12 
 
       numbers and percentages 
 
Referral by Number 
(1)
 % 
   
GP 1,194 40 
Psychiatrist/mental health service 112 4 
Social Services 77 3 
Hospital 38 1 
Community Addiction Team 70 2 
Non- Statutory Agency 32 1 
Legal requirement 52 2 
Probation 185 6 
Prison/ YOC 613 20 
Self 320 11 
Family/Friend 72 2 
Education 32 1 
Other 201 7 
   
Total 2,998 100 
 
 
(1)
 This table excludes 1 individual whose referral details were unknown.
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Table 8. Proposed action of treatment for clients who presented for treatment: 
2011/12 
 
            numbers and percentages 
 
Proposed Action 
(1)(2)
  Number % 
   
Persons 2,999 - 
   
Assessment 2,622 87 
Detoxification 407 14 
Substitute Prescribing 105 4 
Prescribing Contract 83 3 
Counselling 1,623 54 
Family Support 96 3 
Rehabilitation 19 1 
Throughcare 103 3 
Mentoring 406 14 
Education/Information 1,423 47 
No intervention 10 0 
Advised screening for HIV, HEP B or C 146 5 
Not Known - - 
Other 113 4 
 
(1)
 Individuals can report more than one proposed action, and so percentages will not total to 100. 
 
(2)
 The Not Known category has a count of less than five. 
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Table 9.   Main drug of misuse of clients who presented for treatment by 
gender: 2011/12 
          numbers and percentages 
 
Main Problem Drug 
(1)
 Male Female Total 
    
Cannabis 1,091 136 1,227 
Ecstasy 47 8 55 
Cocaine 
(2)
 174 26 200 
Heroin 142 32 174 
Other opiates 
(3)
 160 59 219 
Benzodiazepines 370 335 705 
Codeine & Paracetamol 29 32 61 
Solvents 14 9 23 
Mephedrone/Methedrone 118 32 150 
Other Hypnotics
(4)
 43 59 102 
Other Stimulants
(5)
 32 7 39 
Other Drugs
(6)
 32 12 44 
    
Total 2,252 747 2,999 
 
Percentages 
 
Cannabis 48 18 41 
Ecstasy 2 1 2 
Cocaine 
(2)
 8 3 7 
Heroin 6 4 6 
Other opiates 
(3)
 7 8 7 
Benzodiazepines 16 45 24 
Codeine & Paracetamol 1 4 2 
Solvents 1 1 1 
Mephedrone/Methedrone 5 4 5 
Other Hypnotics
(4)
 2 8 3 
Other Stimulants
(5)
 1 1 1 
Other Drugs
(6)
 1 2 1 
    
Total 100 100 100 
 
 
(1)
 The main drug of misuse is the drug which is causing the client the most problems at the time they presented 
themselves to the Agency for treatment.  
(2)
 The cocaine drug category includes both cocaine powder and crack cocaine. 
(3)
 The „other opiates‟ drug category includes methadone and buprenorphine.   
(4)  
The „other hypnotics‟ drug category includes various hypnotics/sedatives/tranquilizers such as Zopiclone etc.  
(5)
The „other stimulants‟ drug category includes various stimulant drugs, including amphetamines and other „legal 
highs‟. 
(6)  
The „other drugs‟ category includes various drugs such as other hallucinogens. Use of these individual drugs is not 
reported due to small cell counts; this is to ensure individuals cannot be identified. 
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Table 10.   Main drug of misuse of clients who presented for treatment by age: 
2011/12 
            numbers and percentages 
 
Main Problem Drug 
(1)(2)
 Under 18 
years 
18-25 
years 
26 years 
& over 
Total 
     
Cannabis 169 551 507 1,227 
Ecstasy - - 33 55 
Cocaine 
(3)
 - - 136 200 
Heroin - - 137 174 
Other opiates 
(4)
 0 53 166 219 
Benzodiazepines 6 114 585 705 
Codeine & Paracetamol 0 11 50 61 
Solvents 12 - - 23 
Mephedrone/Methedrone 19 69 62 150 
Other Hypnotics
(5)
 - - 92 102 
Other Stimulants
(6)
 - - 26 39 
Other Drugs
(7)
 - - - 44 
     
Total 
(8)
 217 952 1,830 2,999 
 
Percentages 
 
Cannabis 78 58 28 41 
Ecstasy - - 2 2 
Cocaine 
(3)
 - - 7 7 
Heroin - - 7 6 
Other opiates 
(4)
 0 6 9 7 
Benzodiazepines 3 12 32 24 
Codeine & Paracetamol 0 1 3 2 
Solvents 6 - - 1 
Mephedrone/Methedrone 9 7 3 5 
Other Hypnotics
(5)
 - - 5 3 
Other Stimulants
(6)
 - - 1 1 
Other Drugs
(7)
 - - - 1 
     
Total  100 100 100 100 
 
(1)
 The main drug of misuse is the drug which is causing the client the most problems at the time they presented 
themselves to the Agency for treatment.  
(2)
 A complete age breakdown has not been presented for all main drugs as some cells were masked to hide counts of 
less than five and some (with cell counts of more than five) to prevent the value in another cell from being calculated; 
this is to ensure individuals cannot be identified.  These cells have been marked „-„. 
(3)
 The cocaine drug category includes both cocaine powder and crack cocaine. 
(4)
 The „other opiates‟ drug category includes methadone and buprenorphine.   
(5)  
The „other hypnotics‟ drug category includes various hypnotics/sedatives/tranquilizers such as Zopiclone etc.  
(6)
The „other stimulants‟ drug category includes various stimulant drugs, including amphetamines and other „legal 
highs‟. 
(7)  
The „other drugs‟ category includes various drugs such as other hallucinogens. Use of these individual drugs is not 
reported due to small cell counts; this is to ensure individuals cannot be identified. 
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Table 11.   Main drug of misuse of clients who presented for treatment by 
HSCT: 2011/12 
            numbers and percentages 
 
Main Problem Drug 
(1) (2)
 Belfast Northern South 
Eastern 
Southern Western Prison Total 
        
Cannabis 442 54 122 135 204 270 1,227 
Ecstasy 23 - - 6 8 - 55 
Cocaine 
(3)
 73 - 16 19 15 - 200 
Heroin 57 26 11 15 8 57 174 
Other opiates 
(4)
 60 19 32 15 21 72 219 
Benzodiazepines 407 11 191 6 9 81 705 
Codeine & Paracetamol 21 - 11 - 15 8 61 
Solvents 12 - - - - - 23 
Mephedrone/Methedrone 55 9 16 31 30 9 150 
Other Hypnotics 
(5)
 69 0 15 - 0 - 102 
Other Stimulants 
(6)
 6 0 5 6 - - 39 
Other Drugs 
(7)
 14 - 6 - - 18 44 
        
Total 1,239 129 430 243 318 640 2,999 
 
Percentages 
Cannabis 36 42 28 56 64 42 41 
Ecstasy 2 - - 2 3 - 2 
Cocaine 
(3)
 6 - 4 8 5 - 7 
Heroin 5 20 3 6 3 9 6 
Other opiates 
(4)
 5 15 7 6 7 11 7 
Benzodiazepines 33 9 44 2 3 13 24 
Codeine & Paracetamol 2 - 3 - 5 1 2 
Solvents 1 - - - - - 1 
Mephedrone/Methedrone 4 7 4 13 9 1 5 
Other Hypnotics
(5)
 6 0 3 - 0 - 3 
Other Stimulants
(6)
 0 0 1 2 - - 1 
Other Drugs
(7)
 1 - 1 - - 3 1 
        
Total 100 100 100 100 100 100 100 
 
(1)
 The main drug of misuse is the drug which is causing the client the most problems at the time they presented 
themselves to the Agency for treatment.  
(2)
 A complete HSCT breakdown has not been presented for all main drugs as some cells were masked to hide counts 
of less than five and some (with cell counts of more than five) to prevent the value in another cell from being 
calculated; this is to ensure individuals cannot be identified.  These cells have been marked „-„. 
(3)
 The cocaine drug category includes both cocaine powder and crack cocaine. 
(4)
 The „other opiates‟ drug category includes methadone and buprenorphine.   
(5)  
The „other hypnotics‟ drug category includes various hypnotics/sedatives/tranquilizers such as Zopiclone etc.  
(6)
The „other stimulants‟ drug category includes various stimulant drugs, including amphetamines and other „legal 
highs‟. 
(7)  
The „other drugs‟ category includes various drugs such as other hallucinogens. Use of these individual drugs is not 
reported due to small cell counts; this is to ensure individuals cannot be identified. 
 
 Statistical Bulletin PHIRB 3/2012  October 2012  
Statistics from the Northern Ireland Drug Misuse Database, 2011/12   
Page 28 
Table 12.   All drugs of misuse of clients who presented for treatment by 
HSCT: 2011/12 
            numbers and percentages 
 
 All Drugs 
(1) (2)
 Belfast Northern South 
Eastern 
Southern Western Prison Total 
        
Persons 1,239 129 430 243 318 640 2,999 
        
Cannabis 577 77 173 163 253 490 1,733 
Ecstasy 158 14 26 54 91 83 426 
Cocaine 
(3)
 236 18 54 73 100 247 728 
Heroin 78 31 15 19 12 72 227 
Other opiates 
(4)
 122 35 87 27 47 124 442 
Benzodiazepines 661 41 303 32 45 172 1,254 
Codeine & Paracetamol 43 - 77 8 30 - 177 
Solvents 36 - 7 - 7 46 102 
Mephedrone/Methedrone 142 26 45 87 115 40 455 
Other Hypnotics 
(5)
 116 0 50 - 0 - 226 
Other Stimulants 
(6)
 56 12 27 25 45 117 282 
Other Drugs 
(7)
 68 5 20 7 36 99 235 
        
 
Percentages 
 
Cannabis 47 60 40 67 80 77 58 
Ecstasy 13 11 6 22 29 13 14 
Cocaine 
(3)
 19 14 13 30 31 39 24 
Heroin 6 24 3 8 4 11 8 
Other opiates 
(4)
 10 27 20 11 15 19 15 
Benzodiazepines 53 32 70 13 14 27 42 
Codeine & Paracetamol 3 - 18 3 9 - 6 
Solvents 3 - 2 - 2 7 3 
Mephedrone/Methedrone 11 20 10 36 36 6 15 
Other Hypnotics 
(5)
 9 0 12 - 0 - 8 
Other Stimulants 
(6)
 5 9 6 10 14 18 9 
Other Drugs 
(7)
 5 4 5 3 11 15 8 
 
 
(1)
 The main drug of misuse is the drug which is causing the client the most problems at the time they presented 
themselves to the Agency for treatment.  
(2)
 A complete HSCT breakdown has not been presented for all main drugs as some cells were masked to hide counts 
of less than five and some (with cell counts of more than five) to prevent the value in another cell from being 
calculated; this is to ensure individuals cannot be identified.  These cells have been marked „-„. 
(3)
 The cocaine drug category includes both cocaine powder and crack cocaine. 
(4)
 The „other opiates‟ drug category includes methadone and buprenorphine.   
(5)  
The „other hypnotics‟ drug category includes various hypnotics/sedatives/tranquilizers such as Zopiclone etc.  
(6)
The „other stimulants‟ drug category includes various stimulant drugs, including amphetamines and other „legal 
highs‟. 
(7)  
The „other drugs‟ category includes various drugs such as other hallucinogens. Use of these individual drugs is not 
reported due to small cell counts; this is to ensure individuals cannot be identified. 
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Table 13.  Problem alcohol use by HSCT: 2011/12 
 
        numbers and percentages 
 
  
Belfast Northern South 
Eastern 
Southern Western Prison Total 
        
Problem Alcohol Use 
(1)
 405 30 216 157 176 154 1,138 
No Problem Use 831 98 212 86 142 483  1, 852 
        
Total 
(2)
 1,236 128 428 243 318 637 2,990 
 
 
 
Percentages 
 
Problem Alcohol Use 33 23 50 65 55 24 38 
No Problem Use 67 77 50 35 45 76 62 
        
Total 100 100 100 100 100 100 100 
 
(1) 
 596 (52%) of the 1,138 clients reported that alcohol was their main problem. 
 
(2)
 This table excludes 9 individuals for whom alcohol use was not known.   
 
 
Table 14.  Average units of alcohol consumed per week in the four weeks 
before treatment: 2011/12 
 
        numbers and percentages 
 
  
Number % 
   
None 232 23 
1-99 units 461 46 
100-249 units 203 20 
250-549 units 87 9 
550 & more units 23 2 
   
Total 
(3)
 1,006 100 
 
(3)
 This table excludes 132 individuals who reported that they had problem alcohol use but did not 
record the average number of alcohol units consumed per week in the four weeks before treatment. 
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Table 15.   Treatment history of clients who presented for treatment by main 
drug of misuse: 2011/12 
 
        numbers and percentages 
 
Main Problem Drug 
(1) (2)
 Treated before Not treated before Total 
    
Cannabis 288 939 1,227 
Ecstasy 19 36 55 
Cocaine 
(3)
 67 133 200 
Heroin 96 78 174 
Other opiates 
(4)
 74 145 219 
Benzodiazepines 78 627 705 
Codeine & Paracetamol 23 38 61 
Solvents - - 23 
Mephedrone/Methedrone 37 113 150 
Other Hypnotics 
(5)
 8 94 102 
Other Stimulants 
(6)
 - - 39 
Other Drugs 
(7)
 18 26 44 
    
Total 
(7)
 719 2,280 2,999 
 
Percentages 
Cannabis 23 77 100 
Ecstasy 35 65 100 
Cocaine 
(3)
 34 67 100 
Heroin 55 45 100 
Other opiates 
(4)
 34 66 100 
Benzodiazepines 11 89 100 
Codeine & Paracetamol 38 62 100 
Solvents - - 100 
Mephedrone/Methedrone 25 75 100 
Other Hypnotics 
(5)
 8 92 100 
Other Stimulants 
(6)
 - - 100 
Other Drugs 
(7)
 41 59 100 
    
Total  24 76 100 
(1)
 The main drug of misuse is the drug which is causing the client the most problems at the time they presented 
themselves to the Agency for treatment.  
(2)
 A complete HSCT breakdown has not been presented for all main drugs as some cells were masked to hide counts 
of less than five and some (with cell counts of more than five) to prevent the value in another cell from being 
calculated; this is to ensure individuals cannot be identified.  These cells have been marked „-„. 
(3)
 The cocaine drug category includes both cocaine powder and crack cocaine. 
(4)
 The „other opiates‟ drug category includes methadone and buprenorphine.   
(5)  
The „other hypnotics‟ drug category includes various hypnotics/sedatives/tranquilizers such as Zopiclone etc.  
(6)
The „other stimulants‟ drug category includes various stimulant drugs, including amphetamines and other „legal 
highs‟. 
(7)  
The „other drugs‟ category includes various drugs such as other hallucinogens. Use of these individual drugs is not 
reported due to small cell counts; this is to ensure individuals cannot be identified. 
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Table 16.   Age profile of clients at their current treatment, and at their first 
treatment: 2011/12  
 
                    numbers and percentages 
 
 
Clients Age Group at Face Date 
Under 18 years 18-25 years 26 years & 
over 
Total 
Age at first treatment 
(1)
     
Under 18 years 29 44 18 91 
18-25 years 0 115 125 240 
26 years & over 0 0 295 295 
     
Total 29 159 438 626 
 
 
 
Percentages 
 
Age at first treatment 
(1)
     
Under 18 years 100 28 4 15 
18-25 years 0 72 29 38 
26 years & over 0 0 67 47 
     
Total 100 100 100 100 
 
(1)
 This table excludes 93 individuals who reported that they had been previously treated but whose 
age first treated was not known. 
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Table 17.   Route of administration for main drug of misuse by clients who 
presented for treatment: 2011/12 
       numbers and percentages 
 
Main Problem Drug 
(1) (2)
 Inject Oral Smoke Sniff Other Total 
       
Cannabis 0 106 1,091 - - 1,206 
Ecstasy 0 - 0 - - 55 
Cocaine 
(3)
 0 5 19 172 0 196 
Heroin 116 - - - - 174 
Other opiates 
(4)
 - 210 0 - - 219 
Benzodiazepines 0 705 0 0 0 705 
Codeine & Paracetamol 0 61 0 0 0 61 
Solvents 0 - - 19 - 23 
Mephedrone/Methedrone 0 34 13 101 0 148 
Other Hypnotics 
(5)
 0 101 0 0 0 101 
Other Stimulants 
(6)
 - 23 - 9 0 37 
Other Drugs  
(7)
 - 38 0 - - 43 
       
Total 
(8)
 123 1,340 1,183 318 4 2,968 
 
Percentages 
Cannabis 0 9 90 - - 100 
Ecstasy 0 - 0 - - 100 
Cocaine 
(3)
 0 3 10 88 0 100 
Heroin 67 - - - - 100 
Other opiates 
(4)
 - 96 0 - - 100 
Benzodiazepines 0 100 0 0 0 100 
Codeine & Paracetamol 0 100 0 0 0 100 
Solvents 0 - - 83 - 100 
Mephedrone/Methedrone 0 23 9 68 0 100 
Other Hypnotics 
(5)
 0 100 0 0 0 100 
Other Stimulants 
(6)
 - 62 - 24 0 100 
Other Drugs 
(7)
 - 88 0 - - 100 
       
Total 
(8)
 4 45 40 11 0 100 
 
 
(1)
 The main drug of misuse is the drug which is causing the client the most problems at the time they presented 
themselves to the Agency for treatment.  
(2)
 A complete breakdown of route of administration has not been presented for all main drugs as some cells were 
masked to hide counts of less than five and some (with cell counts of more than five) to prevent the value in another 
cell from being calculated; this is to ensure individuals cannot be identified.     
(3)
 The cocaine drug category includes both cocaine powder and crack cocaine. 
(4)
 The „other opiates‟ drug category includes methadone and buprenorphine.   
(5)  
The „other hypnotics‟ drug category includes various hypnotics/sedatives/tranquilizers such as Zopiclone etc.  
(6)
The „other stimulants‟ drug category includes various stimulant drugs, including amphetamines and other „legal 
highs‟. 
(7)  
The „other drugs‟ category includes various drugs such as other hallucinogens. Use of these individual drugs is not 
reported due to small cell counts; this is to ensure individuals cannot be identified. 
(8)
 This table excludes 31 individuals whose route of administration for main drug was not known. 
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Table 18. Injecting history of clients who presented for treatment by HSCT: 
2011/12 
       numbers and percentages 
 
HSCT  Persons who had 
injected 
Persons with known 
injecting history 
   
Belfast 74 1,239 
Northern 31 129 
South Eastern 21 430 
Southern 14 243 
Western 28 318 
   
Prison 50 598 
   
Total 218 2,957 
 
 
 
Percentages 
(1) 
 
Belfast 6 100 
Northern 24 100 
South Eastern 5 100 
Southern 6 100 
Western 9 100 
   
Prison 8 100 
   
Total 7 100 
 
(1)
 The percentage of clients who have ever injected has been based on those whose injecting history 
is known. 
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Table 19.   Age first injected of clients who presented for treatment who had 
ever injected: 2011/12 
 
       numbers and percentages 
 
Age group Number % 
   
Under 18 years 29 14 
18-21 years 79 38 
22-25 years 46 22 
26-29 years 27 13 
30-39 years 19 9 
40 years & over 8 4 
   
Total 
(1)
 208 100 
 
(1)
 This table excludes 10 individuals whose age first injected was not known.   
 
 
 
Table 20.  Gender of injectors (2) who presented for treatment by sharing  
history (3): 2011/12 
 
       numbers and percentages 
 
  Male Female Persons 
    
Individuals who had shared equipment 53 13 66 
Individuals with a known sharing history 
(4)
 173 37 210 
 
 
Percentages 
(5) 
 
Individuals who had shared equipment 31 35 31 
Individuals with a known sharing history 100 100 100 
 
(2)
 Individuals who reported that they had injected at some stage in their lives. 
 
(3)
 Injectors who answered Yes or No to “Ever Shared?” 
 
(4)
 This table excludes 8 individuals whose sharing history was not known. 
 
(5)
 The percentage of clients who have ever shared equipment has been based on those whose 
sharing history is known. 
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Table 21.   Number of clients who have previously been tested for HIV, 
Hepatitis B and Hepatitis C: 2011/12 
 
       numbers and percentages 
 
(a) HIV (1) 
 
  Number % 
   
Ever tested 163 6 
Tested in last 12 months 63 2 
Never tested 2,568 92 
Test status unknown  205 - 
   
Total 2,999  
 
(1)
 The percentage of clients who have ever been tested for HIV is based on those whose HIV test 
status is known.  
 
 
 
(b) Hepatitis B (2) 
 
  Number % 
   
Ever tested 164 6 
Tested in last 12 months 61 2 
Never tested 2,569 92 
Test status unknown 205 - 
   
Total 2,999  
 
(2)
 The percentage of clients who have ever been tested for Hepatitis B is based on those whose 
Hepatitis B test status is known.   
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Table 21 (continued) 
 
(c) Hepatitis C (1) 
 
  Number % 
   
Ever tested 156 6 
Tested in last 12 months 60 2 
Never tested 2,578 92 
Test status unknown 205 - 
   
Total 2,999  
 
(1)
 The percentage of clients who have ever been tested for Hepatitis C is based on those whose 
Hepatitis C test status is known.   
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Table 22. Number of injections clients have completed for the Hepatitis B 
Vaccination Course by HSCT: 2011/12 
       numbers and percentages 
 
                      Number of injections of the Hepatitis B vaccination course completed 
 
HSCT 
(1) (2)
 Zero One Two Three Total 
      
Belfast 1,194 - - 23 1,228 
Northern 107 - - 17 129 
South Eastern 412 0 - - 430 
Southern 237 0 - - 242 
Western 311 - 0 - 317 
      
Prison 477 9 - - 498 
      
Total  2,738 18 12 76 2,844 
 
 
 
Percentages 
 
Belfast 97 - - 2 100 
Northern 83 - - 13 100 
South Eastern 96 0 - - 100 
Southern 98 0 - - 100 
Western 98 - 0 - 100 
      
Prison 96 2 - - 100 
      
Total 96 1 0 3 100 
 
(1)
 A complete breakdown by HSCT is not presented as some cells were masked to hide counts of 
less than five and some (with cell counts of more than five) to prevent the value in another cell from 
being calculated; this is to ensure individuals cannot be identified.     
 
(2)
 This table excludes 155 individuals whose Hepatitis B vaccination course status was not known.   
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Table 23.   Living arrangements of clients who presented for treatment: 
2011/12 
 
       numbers and percentages 
 
 Living arrangements Number % 
   
Alone 714 24 
With spouse/ partner only 226 8 
With spouse/ partner and children 276 9 
With dependent children 122 4 
With parents 634 21 
With friends 65 2 
Hostel 96 3 
Homeless -  Roofless 13 0 
In Prison - YOC 653 22 
Other Specify 200 7 
Not known 0 0 
   
Total 
(1)
 2,999 100 
 
(1)
 171 (6%) of the 2,999 individuals reported living with other drug users. 
 
 
Table 24.   Employment status of clients who presented for treatment: 2011/12 
 
       numbers and percentages 
 
 Employment Status Number % 
   
In Employment 381 13 
On Government training scheme 39 1 
Student 157 5 
Unemployed 1,365 46 
Receiving Other Benefits 256 9 
Retired/ Receiving Pension 119 4 
Other 681 23 
   
Total 
(2) (3)
 2,998 100 
 
(2) 
843 (28%) of the 2,999 individuals reported having worked in the 12 months before treatment 
commenced.  
(3)
This table excludes 1 individual for whom employment status was not known.
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Table 25.   EU nationality of clients who presented for treatment: 2011/12 
 
       numbers and percentages 
 
Nationality Number % 
   
EU National 2,925 98 
Non – EU National 66 2 
   
Total
(1)
 2,991 100 
 
(1) 
This table excludes 8 individuals whose nationality was not known.   
 
 
 
 
 
 
Table 26.   Legal status of clients who presented for treatment: 2011/12 
 
       numbers and percentages 
 
Legal Status 
(2)
 Number % 
   
Persons 2,999 - 
   
None 1,705 57 
Deferred Sentence 29 1 
Community Supervision 228 8 
Awaiting Sentence 72 2 
Trial Pending 180 6 
Arrest Referral 135 5 
In Prison 653 22 
Not Known 5 0 
Other 35 1 
 
(2)  
Individuals can record more than one legal status, and so percentages may not total 100.  
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ANNEX C – COMPARISON TABLES 2010/11 TO 2011/12 
 
TABLE TITLE PAGE 
 
Table C1 
 
 
 
Table C2 
 
 
 
Table C3 
 
 
 
Table C4 
 
 
 
Table C5 
Age and gender of clients who presented for treatment: 
2010/11 and 2011/12 
 
 
Age and gender of clients who presented for treatment by 
HSCT: 2010/11 and 2011/12 
 
 
Main drug of misuse of clients who presented for treatment: 
2010/11 and 2011/12 
 
 
Main drug of misuse of clients who presented for treatment 
by HSCT: 2010/11 and 2011/12 
 
 
Number of clients who presented for treatment who had ever 
injected by HSCT: 2010/11 and 2011/12 
42 
 
 
 
43-48 
 
 
 
49 
 
 
 
50-55 
 
 
 
56 
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Table C1.   Age and gender of clients who presented for treatment: 2010/11 and 
2011/12 
 
       numbers and percentages  
 
 Age groups 2010/11 
(1)
 2011/12 
(2)
 
Males Females Persons Males Females Persons 
       
Under 18 years 181 38 219 181 36 217 
18-21 years 401 79 480 433 68 501 
22-25 years 295 74 369 388 63 451 
26-29 years 268 69 337 338 47 385 
30-39 years 404 137 541 530 146 676 
40 years & over 326 320 646 382 387 769 
       
Total 1,875 717 2,592 2,252 747 2,999 
 
 
 
Percentages 
 
Under 18 years 10 5 8 8 5 7 
18-21 years 21 11 19 19 9 17 
22-25 years 16 10 14 17 8 15 
26-29 years 14 10 13 15 6 13 
30-39 years 22 19 21 24 20 23 
40 years & over 17 45 25 17 52 26 
       
Total 100 100 100 100 100 100 
 
(1) 
The 2010/11 figures exclude 1 individual whose date of birth was unknown. 
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Table C2.   Age and gender of clients who presented for treatment by HSCT: 
2010/11 and 2011/12 
              numbers and percentages  
 
 (a) Belfast HSCT 
 
  
 Age groups  2010/11 
(1)
 2011/12 
  Males Females Persons Males Females Persons 
       
Under 18 years 47 8 55 53 5 58 
18-25 years 354 79 433 279 57 336 
26 years & over 546 329 875 500 345 845 
       
Total 947 416 1,363 832 407 1,239 
 
 
 
Percentages 
 
Under 18 years 5 2 4 6 1 5 
18-25 years 37 19 32 34 14 27 
26 years & over 58 79 64 60 85 68 
       
Total 100 100 100 100 100 100 
 
 (2)
 The 2010/11 figures exclude 1 individual whose date of birth was unknown. 
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Table C2.   Age and gender (continued) 
 
(b) Northern HSCT 
 
 
 
 Age groups
(1)
 2010/11  2011/12  
  Males Females Persons Males Females Persons 
       
Under 18 years - - 41 26 9 35 
18-25 years - - 25 25 9 34 
26 years & over 36 7 43 48 12 60 
       
Total 94 15 109 99 30 129 
 
 
 
Percentages 
 
Under 18 years - - 38 26 30 27 
18-25 years - - 23 25 30 26 
26 years & over 38 47 39 48 40 47 
       
Total 100 100 100 100 100 100 
 
(1)
 A complete gender breakdown has not been presented for 2010/11 as it contained cell counts of 
less than five; this is to ensure individuals cannot be identified.  These cells have been marked „-„. 
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Table C2.   Age and gender (continued) 
 
(c) South Eastern HSCT 
 
 
 Age groups 2010/11  2011/12 
  Males Females Persons Males Females Persons 
       
Under 18 years 12 5 17 27 5 32 
18-25 years 61 23 84 62 24 86 
26 years & over 131 110 241 161 151 312 
       
Total 204 138 342 250 180 430 
 
 
 
Percentages 
 
Under 18 years 6 4 5 11 3 7 
18-25 years 30 17 25 25 13 20 
26 years & over 64 80 70 64 84 73 
       
Total 100 100 100 100 100 100 
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Table C2.   Age and gender (continued) 
 
(d) Southern HSCT 
 
 
 Age groups 2010/11 2011/12 
  Males Females Persons Males Females Persons 
       
Under 18 years 43 8 51 39 7 46 
18-25 years 47 19 66 55 8 63 
26 years & over 87 26 113 115 19 134 
       
Total 177 53 230 209 34 243 
 
 
 
Percentages 
 
Under 18 years 24 15 22 19 21 19 
18-25 years 27 36 29 26 24 26 
26 years & over 49 49 49 55 56 55 
       
Total 100 100 100 100 100 100 
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Table C2.   Age and gender (continued) 
 
(e) Western HSCT 
 
 
 
 Age groups  2010/11 2011/12 
  Males Females Persons Males Females Persons 
       
Under 18 years 32 12 44 29 10 39 
18-25 years 87 24 111 95 25 120 
26 years & over 98 48 146 111 48 159 
       
Total 217 84 301 235 83 318 
 
 
 
Percentages 
 
Under 18 years 15 14 15 12 12 12 
18-25 years 40 29 37 40 30 38 
26 years & over 45 57 49 47 58 50 
       
Total 100 100 100 100 100 100 
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Table C2.   Age and gender (continued) 
 
(f) Prisons 
 
  
 Age groups 2010/11 2011/12 
Males Females Persons Males Females Persons 
       
Under 18 years 11 0 11 7 0 7 
18-25 years 125 5 130 305 8 313 
26 years & over 100 6 106 315 5 320 
       
Total 236 11 247 627 13 640 
 
 
Percentages 
 
Under 18 years 5 0 4 1 0 1 
18-25 years 53 45 53 49 62 49 
26 years & over 42 55 43 50 38 50 
       
Total 100 100 100 100 100 100 
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Table C3.   Main drug of misuse of clients who presented for treatment:  
2010/11 and 2011/12 
 
       numbers and percentages  
 
 Main Problem Drug 
(1)
 2010/11 2011/12 
   
Cannabis 1,048 1,227 
Ecstasy 38 55 
Cocaine 
(2)
 152 200 
Heroin 193 174 
Other opiates 
(3)
 163 219 
Benzodiazepines 500 705 
Codeine & Paracetamol 55 61 
Other Drugs 
(4)
 444 358 
   
Total 2,593 2,999 
 
Percentages 
Cannabis 40 41 
Ecstasy 1 2 
Cocaine 
(2)
 6 7 
Heroin 7 6 
Other opiates 
(3)
 6 7 
Benzodiazepines 19 24 
Codeine & Paracetamol 2 2 
Other Drugs 
(4)
 17 12 
   
Total 100 100 
 
(1)
 The main drug of misuse is the drug which is causing the client the most problems at the time they 
present themselves to the Agency for treatment. 
  
 
(2)
 The cocaine drug category includes both cocaine powder and crack cocaine. 
 
(3)
 The „other opiates‟ drug category includes methadone and buprenorphine.   
 
(4)
 The „other drugs‟ category includes various drugs such as amphetamines, solvents, mephedrone, 
other hallucinogens, other stimulants etc. Use of these individual drugs is not reported due to small 
cell counts; this is to ensure individuals cannot be identified.  These cells have been marked „-„. 
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Table C4.   Main drug of misuse of clients who presented for treatment by 
HSCT: 2010/11 and 2011/12 
 
       numbers and percentages  
(a) Belfast HSCT 
 
 Main Problem Drug 
(1)
 2010/11 2011/12 
   
Cannabis 524 442 
Ecstasy 18 23 
Cocaine 
(2)
 83 73 
Heroin 60 57 
Other opiates 
(3)
 64 60 
Benzodiazepines 356 407 
Codeine & Paracetamol 24 21 
Other Drugs 
(4)
 235 156 
   
Total 1,364 1,239 
 
Percentages 
 
Cannabis 38 36 
Ecstasy 1 2 
Cocaine 
(2)
 6 6 
Heroin 4 5 
Other opiates 
(3)
 5 5 
Benzodiazepines 26 33 
Codeine & Paracetamol 2 2 
Other Drugs 
(4)
 17 13 
   
Total 100 100 
 
(1)
 The main drug of misuse is the drug which is causing the client the most problems at the time they 
present themselves to the Agency for treatment. 
 
 
(2)
 The cocaine drug category includes both cocaine powder and crack cocaine. 
 
(3)
 The „other opiates‟ drug category includes methadone and buprenorphine.   
 
(4)
 The „other drugs‟ category includes various drugs such as amphetamines, solvents, mephedrone, 
other hallucinogens, other stimulants etc. Use of these individual drugs is not reported due to small 
cell counts; this is to ensure individuals cannot be identified. These cells have been marked „-„. 
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Table C4.   Main drug of misuse (continued) 
 
(b) Northern HSCT 
 
 Main Problem Drug 
(1) (2)
 2010/11 2011/12 
   
Cannabis 46 54 
Ecstasy 0 - 
Cocaine 
(3)
 - - 
Heroin 26 26 
Other opiates 
(4)
 11 19 
Benzodiazepines - 11 
Codeine & Paracetamol - - 
Other Drugs 
(5)
 21 - 
   
Total 109 129 
 
 
 
Percentages 
 
Cannabis 42 42 
Ecstasy 0 - 
Cocaine 
(3)
 - - 
Heroin 24 20 
Other opiates 
(4)
 10 15 
Benzodiazepines - 9 
Codeine & Paracetamol - - 
Other Drugs 
(5)
 19 - 
   
Total 100 100 
 
(1)
 The main drug of misuse is the drug which is causing the client the most problems at the time they 
present themselves to the Agency for treatment. 
 
 
(2)
 A breakdown of main problem drug in both 2010/11 and 2011/12 has not been presented for cells 
that have counts of less than five or if the cells were not presented in Table 11; this is to ensure 
individuals cannot be identified.   
 
(3)
 The cocaine drug category includes both cocaine powder and crack cocaine. 
 
(4)
 The „other opiates‟ drug category includes methadone and buprenorphine.   
 
(5)
 The „other drugs‟ category includes various drugs such as amphetamines, solvents, mephedrone, 
other hallucinogens, other stimulants etc. Use of these individual drugs is not reported due to small 
cell counts; this is to ensure individuals cannot be identified.  These cells have been marked „-„. 
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Table C4.   Main drug of misuse (continued) 
 
(c) South Eastern HSCT 
 
 Main Problem Drug 
(1) (2)
 2010/11 2011/12 
   
Cannabis 91 122 
Ecstasy - - 
Cocaine 
(3)
 20 16 
Heroin 13 11 
Other opiates 
(4)
 33 32 
Benzodiazepines 109 191 
Codeine & Paracetamol 13 11 
Other Drugs 
(5)
 - - 
   
Total 342 430 
 
 
 
Percentages 
 
Cannabis 27 28 
Ecstasy - - 
Cocaine 
(3)
 6 4 
Heroin 4 3 
Other opiates 
(4)
 10 7 
Benzodiazepines 32 44 
Codeine & Paracetamol 4 3 
Other Drugs 
(5)
 - - 
   
Total 100 100 
 
(1)
 The main drug of misuse is the drug which is causing the client the most problems at the time they 
present themselves to the Agency for treatment. 
  
 
(2)
 A breakdown of main problem drug in 2010/11 and 2011/12 has not been presented for cells that 
have counts of less than five or if the cells were not presented in Table 11; this is to ensure individuals 
cannot be identified.  These cells have been marked „-„. 
 
(3)
 The cocaine drug category includes both cocaine powder and crack cocaine. 
 
(4)
 The „other opiates‟ drug category includes methadone and buprenorphine.   
 
(5)
 The „other drugs‟ category includes various drugs such as amphetamines, solvents, mephedrone, 
other hallucinogens, other stimulants etc. Use of these individual drugs is not reported due to small 
cell counts; this is to ensure individuals cannot be identified. 
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Table C4.   Main drug of misuse (continued) 
 
(d) Southern HSCT 
 
 Main Problem Drug 
(1) (2)
 2010/11 2011/12 
   
Cannabis 108 135 
Ecstasy - 6 
Cocaine 
(3)
 19 19 
Heroin 34 15 
Other opiates 
(4)
 9 15 
Benzodiazepines - 6 
Codeine & Paracetamol - - 
Other Drugs 
(5)
 47 - 
   
Total 230 243 
 
 
 
Percentages 
 
Cannabis 47 56 
Ecstasy - 2 
Cocaine 
(3)
 8 8 
Heroin 15 6 
Other opiates 
(4)
 4 6 
Benzodiazepines - 2 
Codeine & Paracetamol - - 
Other Drugs 
(5)
 20 - 
   
Total 100 100 
 
(1)
 The main drug of misuse is the drug which is causing the client the most problems at the time they 
present themselves to the Agency for treatment. 
  
 
(2)
 A breakdown of main problem drug in 2010/11 and 2011/12 has not been presented for cells that 
have counts of less than five or if the cells were not presented in Table 11; this is to ensure individuals 
cannot be identified.  These cells have been marked „-„. 
 
(3)
 The cocaine drug category includes both cocaine powder and crack cocaine. 
 
(4)
 The „other opiates‟ drug category includes methadone and buprenorphine.  
  
(5)
 The „other drugs‟ category includes various drugs such as amphetamines, solvents, mephedrone, 
other hallucinogens, other stimulants etc. Use of these individual drugs is not reported due to small 
cell counts; this is to ensure individuals cannot be identified. 
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Table C4.   Main drug of misuse (continued) 
 
(e) Western HSCT 
 
 Main Problem Drug 
(1) (2)
 2010/11 2011/12 
 
Cannabis 166 204 
Ecstasy 12 8 
Cocaine 
(3)
 - 15 
Heroin 8 8 
Other opiates 
(4)
 22 21 
Benzodiazepines 12 9 
Codeine & Paracetamol 11 15 
Other Drugs 
(5)
 - 38 
   
Total 301 318 
 
 
Percentages 
 
Cannabis 55 64 
Ecstasy 4 3 
Cocaine 
(3)
 - 5 
Heroin 3 3 
Other opiates 
(4)
 7 7 
Benzodiazepines 4 3 
Codeine & Paracetamol 4 5 
Other Drugs 
(5)
 - 12 
   
Total 100 100 
 
(1)
 The main drug of misuse is the drug which is causing the client the most problems at the time they 
present themselves to the Agency for treatment.  
 
 
(2)
 A breakdown of main problem drug in 2010/11 has not been presented for cells that have counts of 
less than five or if the cells were not presented in Table 11; this is to ensure individuals cannot be 
identified.  These cells have been marked „-„. 
 
(3)
 The cocaine drug category includes both cocaine powder and crack cocaine. 
 
(4)
 The „other opiates‟ drug category includes methadone and buprenorphine.  
 
(5)
 The „other drugs‟ category includes various drugs such as amphetamines, solvents, mephedrone, 
other hallucinogens, other stimulants etc. Use of these individual drugs is not reported due to small 
cell counts; this is to ensure individuals cannot be identified. 
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Table C4.   Main drug of misuse (continued) 
 
(f) Prisons 
 
  
 Main Problem Drug 
(1) (2)
 2010/11 2011/12 
   
Cannabis 113 270 
Ecstasy - - 
Cocaine 
(3)
 18 - 
Heroin 52 57 
Other opiates 
(4)
 24 72 
Benzodiazepines 15 81 
Codeine & Paracetamol 0 8 
Other Drugs 
(5)
 - 64 
   
Total 247 640 
 
Percentages 
 
Cannabis 46 42 
Ecstasy - - 
Cocaine 
(3)
 7 - 
Heroin 21 9 
Other opiates 
(4)
 10 11 
Benzodiazepines 6 13 
Codeine & Paracetamol 0 1 
Other Drugs 
(5)
 - 10 
   
Total 100 100 
 
(1)
 The main drug of misuse is the drug which is causing the client the most problems at the time they 
present themselves to the Agency for treatment.   
 
(2)
 A breakdown of main problem drug in 2010/11 and 2011/12 has not been presented for cells that 
have counts of less than five or if the cells were not presented in Table 11; this is to ensure individuals 
cannot be identified.  These cells have been marked „-„. 
 
(3)
 The cocaine drug category includes both cocaine powder and crack cocaine. 
 
(4)
 The „other opiates‟ drug category includes methadone and buprenorphine. 
  
(5)
 The „other drugs‟ category includes various drugs such as amphetamines, solvents, mephedrone, 
other hallucinogens, other stimulants etc. Use of these individual drugs is not reported due to small 
cell counts; this is to ensure individuals cannot be identified. 
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Table C5.   Number of clients who presented for treatment who had ever 
injected by HSCT: 2010/11 and 2011/12 
 
                        numbers and percentages  
 
  
 HSCT 2010/11 2011/12 
  Persons who 
had injected 
Persons with 
known 
injecting 
history 
Persons who 
had injected 
Persons with 
known 
injecting 
history 
     
Belfast 69 1,361 74 1,239 
Northern 30 109 31 129 
South Eastern 21 342 21 430 
Southern 31 230 14 243 
Western 10 301 28 318 
Prison 44 166 50 598 
     
Total 
(1) (2)
 205 2,509 218 2,957 
 
  
 
Percentages
 (3) 
 
Belfast 5 100 6 100 
Northern 28 100 24 100 
South Eastern 6 100 5 100 
Southern 13 100 6 100 
Western 3 100 9 100 
Prison 27 100 8 100 
     
Total  8 100 7 100 
 
(1)
 In 2010/11 there were 84 individuals whose injecting history was not known. 
 
(2)
 In 2011/12 there were 42 individuals whose injecting history was not known 
  
(3)
 The percentage of clients who had ever injected has been based on those whose injecting history 
was known.  
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Recent and Future Publications from the Public Health Information and 
Research Branch (PHIRB) 
 
Statistical Bulletins 
Number Title Publication Date 
 
1/2012 
 
 
2/2012 
 
 
 
Statistics from the Northern Ireland Drug Addicts Index 
2011 
 
Statistics on Smoking Cessation Services in Northern 
Ireland 2011/12 
 
 
March 2012 
 
 
October 2012 
 
 
 
 
 
 
Survey Bulletins 
Title Publication Date 
 
Adult Drinking Patterns in Northern Ireland 2011 
 
Drug use in Ireland and Northern Ireland: 2010/11Regional Drug Task 
Force (Ireland) and Health & Social Care Trust (Northern Ireland) 
Results (published jointly with the National Advisory Committee on 
Drugs, Ireland) 
 
Drug Use in Ireland and Northern Ireland: 2010/11 Drug Prevalence 
Survey: Sedatives or Tranquillisers, and Anti-depressants Results 
(published jointly with the National Advisory Committee on Drugs, 
Ireland) 
 
Health Survey Northern Ireland: First Results from 2011/12 survey 
 
 
January 2012 
 
June 2012 
 
 
 
 
October 2012 
 
 
 
 
November 2012 
 
Copies of these publications can be obtained online at: 
http://www.dhsspsni.gov.uk/index/stats_research/stats-public-health.htm 
 
  
 
